Objective: The current study aims to evaluate the neurologic state of perinatally HIV-infected children on combination antiretroviral therapy and to attain a better insight into the pathogenesis of their persistent neurologic and cognitive deficits.
These findings are thought to be caused by various pathophysiologic mechanisms, including early HIV-related damage, ongoing immune activation, and cART toxicity. 9 In perinatally HIV-infected children, CNS invasion of HIV occurs in the first 3 weeks of life, 9 which is among the most important reasons why research concerning their persistent neurologic problems is essential. However, studies investigating these mechanisms in relation to imaging and cognitive parameters, particularly in perinatally HIV-infected children, are limited.
Recently, we found poorer cognitive performance in a study comparing perinatally HIV-infected children to age-, sex-, ethnicityand socioeconomically matched healthy controls. 10 The current study focuses on MRI differences among these groups and explores the potential pathophysiologic mechanisms underlying them.
METHODS Standard protocol approvals, registrations, and patient consents. The ethics committee of the Academic Medical Center approved the study protocol. Informed consent was obtained from parents and children age 12 years and older.
Participants. From December 2012 until January 2014, we approached all perinatally HIV-infected patients between 8 and 18 years of age attending our outpatient clinic. Controls were recruited as described previously. 10 We determined the HIV status of controls by the Diasorin Liaison HIV-1-antigen/ antibody test. Exclusion criteria were chronic (non-HIVassociated) neurologic diseases such as seizure disorders, (history of) intracerebral neoplasms, traumatic brain injury, psychiatric disorders, and MRI contraindications (metal implants or claustrophobia).
Controls were matched for age, sex, ethnicity, and socioeconomic status (SES). Matching for SES, determined using parental educational level and occupational status, was done to account for its effect on cognitive performance. 11 Parental education was scored according to the International Standard Classification of Education. Disease-and therapy-related parameters were collected from the Dutch HIV monitoring foundation database (www.hiv-monitoring.nl). A full description of these parameters was published previously. 10 MRI data acquisition. All images were acquired on a 3.0 T MRI scanner (Intera, Philips Healthcare, Best, the Netherlands) equipped with a 16-channel phased array head coil. Head motion was restricted with foamed material inside the coil. A neuroradiologist examined all images for coincidental findings, and detected 1 HIV-infected patient with an Arnold-Chiari malformation, and 1 control with a retrocerebellar cyst. As these were minor conditions, these children were not excluded. Structural 3D T1-weighted images were acquired using magnetization-prepared rapid acquisition gradient echo ( MRI data processing. Data were anonymized prior to analysis.
Processing was performed using in-house developed software, written in Matlab (The MathWorks, Natick, MA), and was executed on the Dutch Grid, using a Web interface to the e-Bioinfra gateway. 12 T1-weighted images were segmented using Freesurfer Image Analysis suite v5.0. 13 All segmentation inaccuracies were checked manually. Participants with excessive head movements were excluded.
FLAIR images were processed using a semiautomatic technique. After bias-field correction, a mask (mask 1) for WMH was created by intensity thresholding using individually determined intensity thresholds on the level of the quadrigeminal plate. A second mask (mask 2) was created by manual gross contouring of WMH. The final mask (intersection of mask 1 and 2) was created using FSLmaths, manually inspected, and corrected to serve as the WMH map for volume calculation.
For DTI images, head motion and deformations induced by eddy currents were corrected for by an affine registration of the diffusion-weighted images (DWIs) to the non-diffusionweighted image. Gradient directions were corrected by the rotation component of the transformation. The DWIs were resampled isotropically. Rician noise in DWIs was reduced by an adaptive noise filtering method.
14 Diffusion tensors were estimated in a nonlinear least squares sense. From the tensors, fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity, and radial diffusivity (RD) maps were computed. Whole brain WM averaged DTI measures were computed by averaging over the entire skeleton.
A voxel-wise statistical analysis of the DTI data was performed using tract-based spatial statistics (TBSS) implemented in the FMRIB Software Library 4.1.6 (University of Oxford, UK). 15 FA data were aligned into a common space using the nonlinear registration tool FNIRT, which uses a b-spline representation of the registration warp field. 16 The mean FA image was created and thinned to create a mean FA skeleton, representing the centers of all tracts common to the group. Each subject's aligned FA data were then projected onto this skeleton and the resulting data fed into voxel-wise cross-subject statistics.
We pairwise assessed group differences for FA, axial diffusivity, RD, and MD using age, sex, and intracranial volume (ICV) as covariates by means of Randomise, a TBSS statistical tool that computes nonparametric permutations using the generalized linear model. We reported significant values at p , 0.05, using threshold-free cluster enhancement. 17 The number of permutations was set to 500. The principal WM tracts were identified in the John Hopkins University WM probabilistic tractography and ICBM WM label atlases. 18 Neuropsychological assessment. On the same day as the MRI scan, participants underwent a comprehensive neuropsychological assessment (NPA) evaluating intelligence, information processing speed, attention, memory, executive function, and visual-motor function. A description of the methods and results of this NPA was previously published. 10 Statistical analysis. Data entry and management was performed using OpenClinica software. Statistical analyses were carried out using Stata, v12 (StataCorp LP, College Station, TX). Demographic characteristics were compared between groups using the unpaired t test or the Mann-Whitney U test and the x 2 test. Values of brain volumes, WMH, and DTI parameters were compared between groups using regression analyses adjusted for sex, age, and ICV, and additionally for total gray matter (GM) in the WMH model as there is a known association between cortical volume and WMH. 19 Effect sizes were calculated by dividing the difference in mean scores between both groups by their pooled SD.
Associations between disease-related parameters and MRI results (total GM and WM volume, MD, and FA) were investigated using multivariable linear regression models adjusted for age and sex. Volumetric outcomes were additionally adjusted for ICV. We explored associations between MRI parameters and those neuropsychological domains most impaired in the HIV-infected group (total IQ, processing speed index, and attention span) 10 using linear regression models adjusted for age.
RESULTS Participants. In total, 35 HIV-infected and 37 matched healthy children were included. Four HIV-infected children were excluded from MRI examination due to dental braces or claustrophobia. Demographic and disease-related characteristics are shown in table 1. None of the study participants had depression, used antidepressants, or received any other psychiatric treatment. None of the controls had a positive HIV test.
Two HIV-infected children were diagnosed previously with HIV encephalopathy, and 1 with cytomegalovirus encephalitis. The latter was excluded from all analyses. Twenty-eight children (90%) were on cART at inclusion, 27 of whom had suppressed viremia (94%). Two children had stopped therapy for personal reasons within 6 months before inclusion, and 1 child had never been on cART. The latter was not excluded; however, a sensitivity analysis without the cART-naive child did not alter the results (data not shown). HIV-infected children were infected with a variety of HIV subtypes (table e-1 on the Neurology ® Web site at Neurology.org).
Volumetric analysis. The HIV-infected group had lower cortical and total GM volume and a lower WM volume (table 2) . We observed a trend between WM volume and age (coefficient 5 3.5, p 5 0.112), which was predominantly driven by an association in controls (coefficient 5 6.16; p 5 0.037), but not in cases (coefficient 5 2.1; p 5 0.529). We found no specific regions where GM or WM volume differences were more pronounced.
White matter lesions. WMH were seen in 16 cases (59%, mean volume: 2.2 log cm 3 , SD 0.7, range 1.2-3.9) and 6 controls (18%, mean volume: 2.0 log cm 3 , SD 0.3, range 1.5-3.9) (p , 0.001). WMH were found in both the juxtacortical and deep WM, and were not detected in specific cerebral lobes (figure 1). Associations with cognitive performance. In all study participants, GM and WM volumes were associated with a higher IQ (GM:
In the HIV-infected group alone, coefficients were similar but associations were not significant, apart from the total WM volume and IQ (coefficient 0.11, p 5 0.029) (table e-2 and figures e-1 and e-2).
DISCUSSION The current study detected a lower GM and WM volume, a higher WMH lesion load, and poorer WM integrity in otherwise wellcontrolled perinatally HIV-infected children, compared to controls. Early HIV-related CNS damage, as well as ongoing low-grade viral replication and immune activation, may be important elements of the pathophysiologic mechanism behind these findings. The observed cerebral injury was associated with poorer cognitive performance in multiple domains. 10 MRI studies are scarce in cART-treated HIVinfected children. 4 Contrasting our results, one post-cART pediatric study on cerebral volumes detected no global GM or WM differences between HIV-infected youths and age-matched controls. The authors did observe WM atrophy in specific areas, such as the corpus callosum. In addition, they found a focal increase in GM, and carefully attributed it to cell swelling as a result of ongoing infection or cART toxicity. 6 We found no (focal) increase in either GM or WM.
The high prevalence of WMH in HIV-infected children in this study was similar to a previous South African pediatric study from the post-cART era. However, their patients were substantially younger (mean age 2.5 years) and underwent neuroimaging for suspected HIV-related neurologic disease. 7 We had anticipated a lower prevalence of WMH in our cases, who were without suspected intracerebral HIV involvement. An explanation for this finding may be our stronger magnetic field strength of 3.0, since 1.5 T has a reduced sensitivity to subtle WMH. 21 In addition, WM myelination occurs mainly in the first 2 years of life and continues at least up to 5 years of age. 22 The majority of patients in the South African study thus had immature WM, which may have resulted in a different pattern of WMH than in our older patients. Nonetheless, WMH are generally thought to represent myelin loss, vasculopathy, and gliosis, partly due to ongoing immune activation. 9 WMH in perinatally HIV-infected children may therefore increase with age, which would support a higher lesion load in our cases.
The WMH diffusely affected juxtacortical and deep WM of the HIV-infected children, while the South African study observed WMH mainly in the frontal and parietal lobes. 7 Lesions in the juxtacortical WM are described in inflammatory conditions such as multiple sclerosis and have been associated with cognitive functioning. 23, 24 They are less associated with perfusion problems as juxtacortical WM is thought to be better perfused than deeper WM. 25 A notable finding was that WMH were also found in 18% of the controls. As described above, it is agreed upon that it is abnormal for WM to be hyperintense after the second year of life. 22 Thus far, the reported prevalence of WMH in healthy children or adolescents varies from 0% to 31%. Of note, these reports used a 1.5 T scanner and did not use FLAIR but an inferior T2-weighted sequence.
26,27 WMH increase with age, with a prevalence of 11%-21% in adults aged around 64 years to 94% at age 80 years. 26 The considerable proportion of controls with WMH and the variable prevalence in the existing literature warrants further investigation, but also suggests that including a control group was essential to not overestimate the occurrence of WMH in pediatric HIV.
Besides GM atrophy and WMH, HIV-infected patients had a higher MD and a lower FA, suggesting a poorer integrity of WM. 28 Increased axial diffusivity is usually associated with a better WM integrity; however, co-occurring with higher RD, it may represent simultaneous axonal and myelin degeneration. One previous pediatric study investigating cerebral diffusion characteristics of a group of cART-naive HIV-infected children with slow disease progression showed similar results. 8 In our study, TBSS analyses exposed a diffuse pattern of poorer WM integrity, analogous to adult HIV studies that reported a higher MD, RD, and axial diffusivity and a lower FA, generally in many cerebral regions. 29, 30 The difference in FA was less pronounced than in the diffusivity markers. However, the increase of both axial diffusivity and RD in may have partially cancelled out a reduction in FA.
31 Table 2 Comparisons of regional brain volumes, DTI parameters, and WMH volumes between HIV-infected and healthy children Various pathophysiologic mechanisms could underlie the cerebral differences detected in this study. First, HIV-related brain damage inflicted before cART initiation may be irreversible. HIV predominantly infects perivascular macrophages and microglia cells in the CNS, which are thought to produce neurotoxic viral proteins and inflammatory mediators. 9 Associations among the zenith HIV VL, the nadir CD41 T-cell Z score, and FA support this theory. Also, a poorer clinical state at diagnosis was associated with a lower WM volume in this study and with lower IQ reported previously. 10 The association between the time with a low CD41 T-cell count and GM volume may indicate that prolonged immunosuppression plays an additional role in CNS damage. Thus, besides damage done before treatment, ongoing low-grade viral replication may also have adverse consequences for the CNS. 32 This is further illustrated by the lack of increase in WM volumes with age in the HIV-infected children, while it increased in their age-matched peers. However, the median age at cART initiation was approximately 2 years, which may be beyond the window of opportunity to prevent early damage in perinatally HIV-infected children. A pediatric DTI study showed that a higher HIV VL, a lower CD41 T-cell count, and having started a second-line cART were all associated with poorer WM integrity. 33 This implies that adequate continuous treatment is indeed crucial for protection of the CNS.
Nonetheless, cART itself may cause damage to the CNS. 34 For example, efavirenz, a first-line treatment option for children older than 3 years, is strongly associated with relatively mild neurologic side effects such as bizarre dreams, but also-although rarelywith severe psychiatric symptoms such as depression or suicidal ideation. 35 Despite being the largest MRI study in HIVinfected children using healthy, matched controls to date, this study is subject to several limitations. First, it is a cross-sectional assessment and cannot illustrate the course of the cerebral findings over time. A higher proportion of HIV-infected children were immigrants from sub-Saharan Africa, where the occurrence of malnutrition is high. Malnutrition early in life has been associated with cortical atrophy, and the higher proportion of immigrants may therefore have confounded the volumetric results. 36 In addition, the HIV-infected children were infected with a wide variety of HIV subtypes, including clade B and C. Differences in MRI-determined brain volumes have been found between adults with HIV-B and HIV-C infection, 37 and animal studies have postulated that HIV-C is less neuropathogenic than HIV-B. 38 We could not find significant associations between these HIV clades and MRI outcome parameters; however, this may be due to the small number of patients per subtype.
Also, more HIV-infected children were adopted or in foster care than controls. Possible unknown early-life circumstances such as maternal substance abuse, postnatal abuse, or neglect could have had a negative effect on cortical volume. 39, 40 Finally, due to the relatively small sample size, associations between disease-and therapy-related factors, MRI results, and cognitive outcomes may have been incomplete.
Nonetheless, this study shows that HIV-infected children, of whom the majority were long-term virally suppressed with cART, have a lower GM and WM volume, a higher WM lesion load, and decreased WM integrity compared to controls. These differences occur in the context of poor cognitive performance in the HIV-infected group, and larger, longitudinal studies are needed to increase our understanding of the pathogenesis of cerebral injury in perinatally HIV-infected children.
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